{
    "code": "52027689",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027689",
    "time": "2023-03-24 04:39:57",
    "許可證字號": "衛部藥輸字第027689號",
    "註銷狀態": "已註銷",
    "註銷日期": "112\/02\/14",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "113\/06\/20",
    "發證日期": "108\/06\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202768908",
    "中文品名": "吉肺能 240\/20微克膠囊乾粉吸入劑",
    "英文品名": "Zephirus 240mcg\/20mcg inhalation powder, hard capsules",
    "適應症": "Zephirus用於適合複方藥品（吸入型皮質類固醇[inhaled corticosteroid]及長效β2交感神經刺激劑[long-acting β2-agonist]）的成人氣喘常規治療：吸入型皮質類固醇及視需要使用之短效β2交感神經刺激劑無法妥善控制病情的病人。或吸入型皮質類固醇及長效β2交感神經刺激劑已足以控制病情的病人。",
    "劑型": "430吸入用膠囊劑",
    "包裝": "吸入器及60粒膠囊HDPE瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新複方",
    "監視期限": "113\/06\/20",
    "主成分略述": "SALMETEROL XINAFOATE, BUDESONIDE",
    "限制項目": "02輸　入",
    "申請商名稱": "0419901100  天義企業股份有限公司",
    "申請商地址": "臺北市大安區復興南路1段129號5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FBE0042000  SMB TECHNOLOGY S.A.",
            "製造廠廠址": "RUE DU PARC INDUSTRIEL, 39-6900 MARCHE-EN-FAMENNE, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1216002910",
            "成分名稱": "SALMETEROL XINAFOATE",
            "含量描述": "(Salmeterol base......0.025 MG)(mean delivered dose......0.020 MG)",
            "含量": "0.0363000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8406002100",
            "成分名稱": "BUDESONIDE",
            "含量描述": "(mean delivered dose......0.240 MG)",
            "含量": "0.3000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Zephirus-inhaler device-108-09-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027689&Seq=002&Type=10"
        },
        {
            "title": "Zephirus-240-capsule-108-09-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027689&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Zephirus-leaflet out-108-09-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027689&Seq=001&Type=9"
        },
        {
            "title": "Zephirus-240-sticker-108-09-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027689&Seq=002&Type=8"
        },
        {
            "title": "Zephirus-240-carton-108-09-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027689&Seq=001&Type=8"
        }
    ]
}